Registreer u om meldingen in te stellen voor instrumenten, economische gebeurtenissen en artikelen van de auteurs die u volgt.
Gratis registreren Heeft u al een account? Inloggen
Noteringen
Alle soorten instrumenten
- Alle soorten instrumenten
- Indexen
- Aandelen
- ETF's
- Fondsen
- Grondst.
- Valuta's
- Crypto
- Obligaties
- Certificaten
Probeer een andere zoekopdracht
🏃 Profiteer vroeg van deze Black Friday-actie en krijg nu tot wel 55% korting op InvestingPro!
BENUT DE SALE
Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc (0P0000X6LO)
Toevoegen/Verwijderen van een Portfolio
Voeg toe aan Portfolio
125,440
-0,830
-0,66%
11/11 - Gesloten. Valuta in EUR
Type:
Fonds
Markt:
Ierland
Emittent:
UBS Fund Management (Luxembourg) S.A.
ISIN:
IE00B841P542
Activaklasse:
Aandeel
- Beoordeling Morningstar:
- Totale activa: 2,23M
UBS (Irl) Investor Selection - Equity Opportunity
125,440
-0,830
-0,66%
- Overzicht
- Profiel
- Historische data
- Participaties
0P0000X6LO Overzicht
Op deze pagina vindt u een uitgebreid profiel van Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc. Kom meer te weten over onder meer het senior management, de totale activa, de investeringsstrategie en de contactgegevens van 0P0000X6LO.
Totale activa
2,23M
Uitgaven
0,93%
Ingangsdatum
26.11.2012
Contact Informatie
Adres
"1st Floor, College Park House, South Frederick Street"
Dublin,
Ireland
Dublin,
Ireland
Telefoon
-
Topmanagers
| Naam | Titel | Sinds | Tot |
|---|---|---|---|
| Scott Wilkin | - | 2024 | now |
| Biografie | Scott is the Head of the Global Intrinsic Value Equity team and co-PM for our Global equity portfolios. He is also Director of Research (DOR); responsible for managing the 13-member analyst team and driving research quality standards across the Global Intrinsic Value platform. In 2012, Scott was promoted to the position of DOR for the US Intrinsic Value equity team. In this role, Scott managed a team of six sector-based analysts and lead company and industry-level research. Scott was also the lead portfolio manager of the Intrinsic Value equity team's Global Healthcare and UBS Healthcare Long/Short strategies. Prior to being named DOR and portfolio manager, Scott was a Senior Investment Analyst and Sector Head for the health care analyst team. His responsibilities included fundamental company and industry-level research. | ||
| Florian Töpfl | - | 2024 | now |
| Dimitrios Goumenos | - | 2024 | now |
| Jeremy Leung | - | 2010 | 2024 |
| Biografie | Jeremy Leung is Portfolio Manager on the Concentrated Alpha Equity team at UBS Asset Management. He is responsible for supporting the investment process and strategy communication for the team. Prior to undertaking his role in March 2011, Jeremy was a Quantitative Analyst within the Equities Group. He was responsible for conducting quantitative and fundamental research for the Group’s investment teams. He also worked extensively on the Group’s fundamental equity valuation model. Prior to joining UBS in 2007, Jeremy worked as a consultant for FactSet Research Systems. He was responsible for providing advice and support to large investment managers across Europe on various analytical tools for investing. Jeremy is a Regular Member of the CFA Society of the UK and the CFA Institute. | ||
| Maximilian Anderl | - | 2010 | 2024 |
| Biografie | Maximilian Anderl is Head of Concentrated Alpha Equity within UBS Asset Managment and is the lead portfolio manager for the Global and European Concentrated Alpha long only and long / short strategies. Maximilian has worked on the Concentrated Alpha team and its distinctive approach and strategies since its inception in 2004, becoming head of that team in January 2011. Maximilian joined the European Equity Team in London in 2002, having joined UBS Asset Management, Zurich, in 2000 as an equity fund manager. In that role he was responsible for the retail funds and European client mandates. Prior to joining UBS, Maximilian worked in academic research, university teaching, research and development and corporate finance for the pharmaceutical industry. Maximilian is a Regular Member of the CFA Society of the UK and the CFA Institute. | ||
| Marc Schaffner | - | 2017 | 2019 |
| Biografie | Marc Schaffner is part of the Investment Solutions team, where he is responsible for implementing strategy decisions taken by the Swiss Investment Committee into client portfolios. He is also a member of the Multi-Asset Investment Committee in his role as senior investment strategist for Switzerland and EMEA across client segments. Prior to joining UBS in 2001, Marc worked for a smaller company doing asset management on a fund basis. He was responsible for a Hedge Fund of Funds and was involved in the fund selection and the asset allocation process of various other portfolios. Marc is a member of the Swiss Investment Committee in Zurich. | ||
Laat weten wat u vindt van Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc
Weet u zeker dat u deze grafiek wilt verwijderen?
Verwijderen Annuleren
Vervang de toegevoegde grafiek met een nieuwe grafiek?
Vervang Annuleren
Richtlijnen voor commentaar
Voeg Grafiek toe aan Commentaar
Blokkering bevestigen
Weet u zeker dat u %USER_NAME% wilt blokkeren?
Als u dit doet, kunnen u en %USER_NAME% geen publicaties meer van elkaar zien op Investing.com.
%USER_NAME% is toegevoegd aan uw lijst met geblokkeerde personen
Omdat u de blokkering van deze persoon net hebt opgeheven, moet u 48 uur wachten om hem/haar weer te kunnen blokkeren.
Rapporteer dit commentaar
Ik vind dit commentaar
Commentaar gemarkeerd
Bedankt!
Uw bericht is ter beoordeling verstuurd naar de moderatoren